166 related articles for article (PubMed ID: 33648421)
21. Cytotoxic T-lymphocyte elicited therapeutic vaccine candidate targeting cancer against MAGE-A11 carcinogenic protein.
Kumar N; Sood D; Gupta A; Jha NK; Jain P; Chandra R
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169789
[TBL] [Abstract][Full Text] [Related]
22. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.
Sirohi PR; Gupta J; Somvanshi P; Prajapati VK; Grover A
J Biomol Struct Dyn; 2022 May; 40(8):3347-3358. PubMed ID: 33246394
[TBL] [Abstract][Full Text] [Related]
23. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
[TBL] [Abstract][Full Text] [Related]
24. Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach.
Abdulla F; Adhikari UK; Uddin MK
Microb Pathog; 2019 Dec; 137():103791. PubMed ID: 31606417
[TBL] [Abstract][Full Text] [Related]
25. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).
Kazanji M; Heraud JM; Merien F; Pique C; de Thé G; Gessain A; Jacobson S
J Gen Virol; 2006 May; 87(Pt 5):1331-1337. PubMed ID: 16603536
[TBL] [Abstract][Full Text] [Related]
26.
Shanthappa PM; Suravajhala R; Suravajhala P; Kumar G; Melethadathil N
J Biomol Struct Dyn; 2023; 41(12):5696-5706. PubMed ID: 35916029
[TBL] [Abstract][Full Text] [Related]
27. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
[TBL] [Abstract][Full Text] [Related]
28.
Almalki S; Beigh S; Akhter N; Alharbi RA
Saudi J Biol Sci; 2022 Jun; 29(6):103283. PubMed ID: 35574284
[TBL] [Abstract][Full Text] [Related]
29. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
30. Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach.
Oany AR; Emran AA; Jyoti TP
Drug Des Devel Ther; 2014; 8():1139-49. PubMed ID: 25187696
[TBL] [Abstract][Full Text] [Related]
31. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.
Dewi SK; Ali S; Prasasty VD
Curr Comput Aided Drug Des; 2019; 15(2):120-135. PubMed ID: 30280672
[TBL] [Abstract][Full Text] [Related]
32. Immunoinformatics designed T cell multi epitope dengue peptide vaccine derived from non structural proteome.
Krishnan G S; Joshi A; Akhtar N; Kaushik V
Microb Pathog; 2021 Jan; 150():104728. PubMed ID: 33400987
[TBL] [Abstract][Full Text] [Related]
33.
Ali MC; Khatun MS; Jahan SI; Das R; Munni YA; Rahman MM; Dash R
J Biomol Struct Dyn; 2022; 40(21):10696-10714. PubMed ID: 36529187
[TBL] [Abstract][Full Text] [Related]
34. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
[TBL] [Abstract][Full Text] [Related]
35. Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein-Barr virus.
Olotu FA; Soliman MES
Biomed J; 2021 Jun; 44(3):317-337. PubMed ID: 34154948
[TBL] [Abstract][Full Text] [Related]
36. Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach.
Ayyagari VS; T C V; K AP; Srirama K
J Biomol Struct Dyn; 2022 Apr; 40(7):2963-2977. PubMed ID: 33252008
[TBL] [Abstract][Full Text] [Related]
37. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach.
Bhatnager R; Bhasin M; Arora J; Dang AS
J Biomol Struct Dyn; 2021 Sep; 39(15):5690-5705. PubMed ID: 32619134
[TBL] [Abstract][Full Text] [Related]
38. Mining of Ebola virus genome for the construction of multi-epitope vaccine to combat its infection.
Shankar U; Jain N; Mishra SK; Sk MF; Kar P; Kumar A
J Biomol Struct Dyn; 2022 Jul; 40(11):4815-4831. PubMed ID: 33463407
[TBL] [Abstract][Full Text] [Related]
39. Design of a multi-epitope peptide vaccine candidate against chandipura virus: an immuno-informatics study.
Pavitrakar DV; Atre NM; Tripathy AS; Shil P
J Biomol Struct Dyn; 2022 Feb; 40(2):648-659. PubMed ID: 32897148
[TBL] [Abstract][Full Text] [Related]
40. An Immunoinformatics Approach in Design of Synthetic Peptide Vaccine Against Influenza Virus.
Lohia N; Baranwal M
Methods Mol Biol; 2020; 2131():229-243. PubMed ID: 32162257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
